Crucell at a Glance
Who we are
Crucell is a fully–integrated biopharmaceutical company. We focus on developing, producing and marketing products to combat infectious diseases. We are the largest independent vaccine company in the world.
Strategy
We develop products that address currently unmet medical needs, particularly in the field of infectious diseases. We have a fully-integrated infrastructure for in-house development, production and marketing of vaccines, and we are now leveraging our knowledge in this area to enter the antibodies market. Our competitive edge comes from our proprietary technology platforms, such as PER.C6®, used to produce high-value biotech products in scalable and cost-efficient ways. This combination of markets, knowledge and tools positions us to be a major player in the multi-billion dollar biotech arena.
Key partnerships
In addition to our own research and development activities, we have formed strategic partnerships with several leading companies. Through these agreements, our technologies are playing a vital role in the development of a number of vaccine and antibody products. Our strategic partners include:
- DSM Biologics
- Novartis
- MedImmune
- Merck
- sanofi pasteur
- Wyeth
Why infectious diseases?
Infectious diseases currently account for a significant number of human deaths worldwide. The number of infectious outbreaks is increasing for many reasons: higher population density raises potential for exposure to infectious agents; an ageing population is more susceptible to infection; and the volume of global travel boosts the potential for spreading diseases internationally.